Dr. Janet Serle, M.D

NPI: 1487652061
Total Payments
$221,001
2022 Payments
$4,116
Companies
9
Transactions
176

Payment Breakdown by Category

Consulting$106,755 (48.3%)
Other$81,895 (37.1%)
Travel$25,620 (11.6%)
Food & Beverage$6,691 (3.0%)
Education$39.95 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $106,755 18 48.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $42,195 15 19.1%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $39,700 14 18.0%
Travel and Lodging $25,620 53 11.6%
Food and Beverage $6,691 75 3.0%
Education $39.95 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Aerie Pharmaceuticals, Inc. $97,566 61 $0 (2021)
Bausch & Lomb, a division of Bausch Health US, LLC $54,796 79 $0 (2020)
Glaukos Corporation $32,872 3 $0 (2019)
Allergan, Inc. $29,302 22 $0 (2020)
Alcon Vision LLC $4,116 1 $0 (2022)
Valeant Pharmaceuticals North America LLC $1,776 4 $0 (2017)
Alcon Laboratories Inc $372.77 3 $0 (2018)
NEW WORLD MEDICAL,INC. $147.42 1 $0 (2017)
Ocular Therapeutix, Inc. $52.46 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2022 $4,116 1 Alcon Vision LLC ($4,116)
2021 $2,138 2 Aerie Pharmaceuticals, Inc. ($2,138)
2020 $11,131 9 Aerie Pharmaceuticals, Inc. ($6,978)
2019 $85,344 49 Aerie Pharmaceuticals, Inc. ($38,372)
2018 $112,257 104 Aerie Pharmaceuticals, Inc. ($50,079)
2017 $6,015 11 Allergan Inc. ($3,942)

All Payment Transactions

176 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
01/27/2022 Alcon Vision LLC rocklatan (Drug), rhopressa Consulting Fee Cash or cash equivalent $4,116.00 General
Category: Glaucoma
06/09/2021 Aerie Pharmaceuticals, Inc. rhopressa (Drug), rocklatan Food and Beverage In-kind items and services $121.81 General
Category: Glaucoma
03/18/2021 Aerie Pharmaceuticals, Inc. rhopressa (Drug), rocklatan Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,016.00 General
Category: Glaucoma
12/14/2020 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Consulting Fee Cash or cash equivalent $915.00 General
Category: OPHTHALMOLOGY
07/01/2020 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Consulting Fee Cash or cash equivalent $1,830.00 General
Category: OPHTHALMOLOGY
07/01/2020 Aerie Pharmaceuticals, Inc. rocklatan (Drug), rhopressa Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,730.00 General
Category: Glaucoma
06/24/2020 Allergan, Inc. DURYSTA (Drug) Education In-kind items and services $39.95 General
Category: GLAUCOMA
05/01/2020 Aerie Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $1,787.50 General
03/24/2020 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Food and Beverage In-kind items and services $36.58 General
Category: OPHTHALMOLOGY
03/17/2020 Aerie Pharmaceuticals, Inc. rocklatan (Drug), rhopressa Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,460.00 General
Category: Glaucoma
02/18/2020 Bausch & Lomb, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $111.81 General
02/10/2020 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Consulting Fee Cash or cash equivalent $1,220.00 General
Category: OPHTHALMOLOGY
11/26/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $2,100.00 General
Category: OPHTHALMOLOGY
11/26/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Travel and Lodging Cash or cash equivalent $32.11 General
Category: OPHTHALMOLOGY
11/25/2019 Allergan Inc. Consulting Fee Cash or cash equivalent $1,300.00 General
11/14/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Food and Beverage In-kind items and services $122.86 General
Category: OPHTHALMOLOGY
11/13/2019 Glaukos Corporation Consulting Fee Cash or cash equivalent $29,342.00 General
11/13/2019 Glaukos Corporation Travel and Lodging Cash or cash equivalent $3,404.51 General
10/17/2019 Aerie Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $7,800.00 General
10/12/2019 Aerie Pharmaceuticals, Inc. Rhopressa (Drug), Rocklatan Food and Beverage In-kind items and services $146.20 General
Category: Glaucoma
10/11/2019 Allergan Inc. Food and Beverage In-kind items and services $57.80 General
10/04/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $2,100.00 General
Category: OPHTHALMOLOGY
10/04/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Travel and Lodging Cash or cash equivalent $180.78 General
Category: OPHTHALMOLOGY
09/26/2019 Bausch & Lomb, a division of Bausch Health US, LLC LOTEMAX SM (Drug) Food and Beverage In-kind items and services $125.00 General
Category: OPHTHALMOLOGY
09/24/2019 Bausch & Lomb, a division of Bausch Health US, LLC VYZULTA (Drug) Food and Beverage In-kind items and services $120.56 General
Category: OPHTHALMOLOGY

About Dr. Janet Serle, M.D

Dr. Janet Serle, M.D is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487652061.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janet Serle, M.D has received a total of $221,001 in payments from pharmaceutical and medical device companies, with $4,116 received in 2022. These payments were reported across 176 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($106,755).

Practice Information

  • Specialty Ophthalmology
  • Other Specialties Glaucoma Specialist
  • Location New York, NY
  • Active Since 07/08/2005
  • Last Updated 07/05/2017
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1487652061

Products in Payments

  • VYZULTA (Drug) $55,763
  • Rhopressa (Drug) $50,350
  • VRAYLAR (Drug) $20,204
  • Rocklatan (Drug) $13,911
  • rocklatan (Drug) $9,306
  • rhopressa (Drug) $2,138
  • LOTEMAX GEL (Drug) $298.35
  • Centurion (Device) $222.77
  • Ahmed Glaucoma Valve (Device) $147.42
  • XEN (Device) $134.20
  • ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $125.00
  • LOTEMAX SM (Drug) $125.00
  • LATANOPROST (Drug) $111.73
  • ReSure Sealant (Device) $52.46
  • DURYSTA (Drug) $39.95
  • TIMOPTIC OCUDOSE (Drug) $39.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in New York